Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial
about
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspectiveDevelopments in the treatment of visceral leishmaniasisA curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapyCost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinentSafety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEfficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label studyDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Leishmaniasis.Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.Leishmaniasis: new approaches to disease control.Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trialTreatment of visceral leishmaniasis.Liposomal amphotericin B and leishmaniasis: dose and responseClinical and experimental advances in treatment of visceral leishmaniasis.Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India.Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.Pharmacotherapeutic options for visceral leishmaniasis-current scenario.Treatment options for visceral leishmaniasis.Quantitative PCR in epidemiology for early detection of visceral leishmaniasis cases in India.Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.Treatment of visceral leishmaniasis: a review of current treatment practices.Structures, targets and recent approaches in anti-leishmanial drug discovery and development.Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 studySpecies-directed therapy for leishmaniasis in returning travellers: a comprehensive guideNew challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.Renal involvement in leishmaniasis: a review of the literatureProgress in the treatment of a neglected infectious disease: visceral leishmaniasis.The development and clinical evaluation of second-generation leishmaniasis vaccines.Liposomal amphotericin B: clinical experience and perspectives.Optimal control and cost-effective analysis of malaria/visceral leishmaniasis co-infection.Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™).Liposomal amphotericin B as a treatment for human leishmaniasisMiltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management.Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.Microscopy and polymerase chain reaction detection of Leishmania chagasi in the pleural and ascitic fluid of a patient with AIDS: Case report and review of diagnosis and therapy of visceral leishmaniasis.N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India.Therapeutic options for visceral leishmaniasis.Leishmaniasis: new insights from an old and neglected disease.
P2860
Q28073426-53F15F86-DA64-440B-B0F0-C895EAA6BD30Q28256441-B4CEC851-A04F-4973-B74B-DEBD677CFD91Q28474921-42BFF5F1-B122-44CF-8216-DE8A961458FDQ28475431-A4400E19-5001-4043-A1C1-81C92B628C62Q28538775-F16E822F-40D6-4A17-B24F-1F46181B5B51Q28543060-1B6272B6-3CBA-4D15-90E9-3D455C40B4A4Q30275257-ED977EE5-B4F7-4307-8BF4-542E27223D4BQ31107638-8D11FEC8-3030-401B-A42E-C8A6B8668113Q33748160-4EA9D0D8-2540-4143-99A2-5C5FF6AE3716Q33813871-0445CBE6-6DB1-4405-8401-42BA2571FF9CQ33898691-D5340198-74AB-4D6D-AA85-AC6E6049ACB3Q33929849-FB83808E-865D-49C6-BD6C-2B9788262ACEQ33929854-2F4A63AB-B1C7-4345-BBB9-692CA1B985C6Q33982648-AC66072A-2C52-40AA-9783-C6F33E8CCC7EQ34024866-91780BED-5CBA-4006-BE55-043AC6937DD1Q34230457-9A1EE830-6D60-4713-A252-FFDDD2E7B4D6Q34342651-4C436B5E-1B38-4EB9-8E4F-BD36A7229B0DQ34510966-7EBCCE8E-D24B-4F0C-B4B5-67FF444489A7Q34680480-E4941016-4B28-40C2-BD8B-E527C21A35BCQ34704669-2FC5C181-48E1-4C96-A2F0-D261719FE5F2Q34768497-4549669C-C55F-4047-BB83-FDB81FD70FF7Q35012968-E096CA58-CED9-4B0B-A2F8-15E33370FF53Q35095252-7BCD7D58-16DA-456E-A5B3-EF20D1A035EEQ35150268-A52B36B2-C706-428D-8B48-B2950E01A4C8Q35160905-01A46F89-F905-48C2-8AA5-94989A3D4CEEQ35219247-84E0EA6A-048C-49CD-9653-5CC434611707Q35574387-1ED62099-CA02-4CA0-BD54-87039B8DBB91Q35917392-ACCA445B-3746-4CE6-B339-26E7A6E221F2Q35986733-7B6C272A-151A-4C75-89A7-738A64A4F856Q36140647-0827B1ED-4EA9-463F-B3BB-4171BB0FD97DQ36271850-9FE0E5CD-5F77-4D7A-B0C9-80720A807468Q36455848-D674561E-2AED-4B16-A00A-E51F3BFE15F7Q36456032-C17D913F-A5FE-419F-B0B9-AC0CB5BB6644Q36645795-6A4F5FBF-FAB3-45D0-A595-3F247B63CABFQ36958635-CEB44427-8FBD-42DE-9157-8772CB6A5E3DQ37045139-D9D88EB6-AD09-4A0F-8A1F-B4E362995EEFQ37159459-DBBC830E-2151-469E-91C7-4562A566872BQ37230269-436D3D98-9389-480D-B7F6-E7568D64EE74Q37333942-4AE70342-D56F-4223-9BB1-3011C4E566CBQ37870821-16713C6D-38CE-49DA-9B55-5A500086FAA5
P2860
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of Indian visceral l ...... photericin B: randomised trial
@ast
Treatment of Indian visceral l ...... photericin B: randomised trial
@en
Treatment of Indian visceral l ...... photericin B: randomised trial
@nl
type
label
Treatment of Indian visceral l ...... photericin B: randomised trial
@ast
Treatment of Indian visceral l ...... photericin B: randomised trial
@en
Treatment of Indian visceral l ...... photericin B: randomised trial
@nl
prefLabel
Treatment of Indian visceral l ...... photericin B: randomised trial
@ast
Treatment of Indian visceral l ...... photericin B: randomised trial
@en
Treatment of Indian visceral l ...... photericin B: randomised trial
@nl
P2093
P2860
P3181
P356
P1433
P1476
Treatment of Indian visceral l ...... photericin B: randomised trial
@en
P2093
P2860
P304
P3181
P356
10.1136/BMJ.323.7310.419
P407
P50
P577
2001-08-25T00:00:00Z